Amyloid β 1 – 42 deposits do not lead to Alzheimer ’ s neuritic plaques in aged dogs
Amyloid β 1 – 42 deposits do not lead to Alzheimer ’ s neuritic plaques in aged dogs
复制标题
淀粉样蛋白 β 1 – 42 沉积物不会导致老年犬出现阿尔茨海默氏症神经炎斑块
DOI:
--
复制
发表时间:
1996
期刊:
影响因子:
--
通讯作者:
B. Frangione
中科院分区:
文献类型:
--
作者:
T. Wisniewski;M. Lalowski;M. Bobik;M. Russell;J. Strosznajder;B. Frangione
Alzheimer’s disease (AD) is neuropathologically defined by the deposition of amyloid in the form of senile plaques, congophilic angiopathy and neurofibrillary tangles (reviewed in [1]). The major constituent of both senile plaques and congophilic angiopathy is a 39–44 amino acid residue peptide, amyloid β (Aβ) [2–8]. Aβ is found, at low concentrations, as a normal constituent of biological fluids, where it is called soluble Aβ (sAβ) [9-12]. sAβ is predominantly Aβ1–40, although shorter and longer sequences exist, including Aβ1–28 and Aβ1–42 [13]. Neuritic plaque amyloid was first sequenced in 1985 [3] and was found to extend mainly to Aβ42}43, while vascular amyloid was initially reported to extend to Aβ1–28 [2] and later to Aβ 39}40 [5,14]. This heterogeneity at the C-terminus of Aβ was attributed to differences in the local tissue processing. More recent reports using different techniques have also found Aβ42 in vascular amyloid deposits [15]. Aβ in both types of amyloid deposits has a predominantly β-sheet structure; on the other hand, sAβ presumably is more random-coil and}or α-helical. An early stage in the development of senile plaques are ‘preamyloid’ or diffuse plaques [16–18]. This is based in part on studies in Down’s syndrome (DS) individuals, where diffuse plaques occur at a very early age, preceding the development of senile plaques [19–21]. Preamyloid deposits are ‘cotton-wool-like areas ’ that are immunoreactive with anti-Aβ antibodies, have irregular borders and are associated with few dystrophic neurites [16–18]. Preamyloid deposits are not stained by Congo Red or Thioflavine S, and ultrastructurally are composed mainly of amorphous, non-fibrillar material. Aged individuals can have large numbers of diffuse plaques without any signs of neuronal dysfunction or dementia [22–24]. We hypothesize that senile plaque formation can be viewed as having at least two major steps, whereby sAβ first undergoes a conformational change and aggregates into preamyloid deposits and this is followed by a gradual process of compaction and fibrillization over many years. It is only in this form that significant toxicity has been documented with synthetic